Second Ebola vaccine will be deployed in the DRC next month

An experimental Ebola vaccine from Johnson & Johnson will be deployed in mid-October to treat at-risk populations in regions that don’t have active Ebola transmission, according to the World Health Organization. This vaccine is the second to be used in the Democratic Republic of the Congo, which has been dealing with a deadly Ebola outbreak for more than a year. … Continue reading